180 related articles for article (PubMed ID: 33819849)
1. Local excision and chemoradiation for clinical node-negative anal adenocarcinoma.
Chatani PD; Dominguez DA; Aversa JG; Davis JL; Hernandez JM; Lai LL; Blakely AM
Surg Oncol; 2021 Jun; 37():101551. PubMed ID: 33819849
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
[TBL] [Abstract][Full Text] [Related]
3. Inguinal Lymph Node Dissection Does Not Improve Overall Survival in Anal Cancer Nodal Disease.
Lin ACH; Hakim A; Kellish AS; Singh P; Wozniak M; Kwiatt M; Gaughan J; Hong YK
J Surg Res; 2020 Nov; 255():13-22. PubMed ID: 32540576
[TBL] [Abstract][Full Text] [Related]
4. Survival Outcomes After Initial Treatment for Anal Adenocarcinoma: A Population-Based Cohort Study.
Park H
Clin Colorectal Cancer; 2020 Sep; 19(3):e75-e82. PubMed ID: 32389595
[TBL] [Abstract][Full Text] [Related]
5. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
6. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
7. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
Leon O; Hagberg O; Johnsson A
Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
[TBL] [Abstract][Full Text] [Related]
8. Association of Time Between Radiation and Salvage APR and Margin Status in Patients With Anal Cancer Treated With Concurrent Chemoradiation.
Lee GC; Ricciardi R; Stafford C; Hong TS; Francone TD; Bordeianou LG; Kunitake H
Am Surg; 2020 Jun; 86(6):703-714. PubMed ID: 32683973
[TBL] [Abstract][Full Text] [Related]
9. Survival Outcomes and Patterns of Management for Anal Adenocarcinoma.
Lewis GD; Haque W; Butler EB; Teh BS
Ann Surg Oncol; 2019 May; 26(5):1351-1357. PubMed ID: 30719638
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer.
Venigalla S; Chowdhry AK; Wojcieszynski AP; Lukens JN; Plastaras JP; Metz JM; Ben-Josef E; Mahmoud NN; Reiss KA; Shabason JE
Clin Colorectal Cancer; 2018 Sep; 17(3):e557-e568. PubMed ID: 29910004
[TBL] [Abstract][Full Text] [Related]
11. Propensity-score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II-III anal adenocarcinoma.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
J Surg Oncol; 2023 Sep; 128(4):585-594. PubMed ID: 37183543
[TBL] [Abstract][Full Text] [Related]
12. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
13. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
[TBL] [Abstract][Full Text] [Related]
14. Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management.
Lukovic J; Kim JJ; Liu ZA; Cummings BJ; Brierley JD; Wong RKS; Ringash JG; Dawson LA; Barry A; Krzyzanowska MK; Chen EX; Hedley DW; Quereshy FA; Swallow CJ; Gryfe RN; Kennedy ED; Easson AM; Hosni A
Dis Colon Rectum; 2022 Feb; 65(2):189-197. PubMed ID: 34990422
[TBL] [Abstract][Full Text] [Related]
15. Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian Population.
Patel SV; Ko G; Raphael MJ; Booth CM; Brogly SB; Kalyvas M; Li W; Hanna T
Dis Colon Rectum; 2020 Jun; 63(6):748-757. PubMed ID: 32384405
[TBL] [Abstract][Full Text] [Related]
16. Patterns of recurrence in anal canal carcinoma.
Faynsod M; Vargas HI; Tolmos J; Udani VM; Dave S; Arnell T; Stabile BE; Stamos MJ
Arch Surg; 2000 Sep; 135(9):1090-3; discussion 1094-5. PubMed ID: 10982516
[TBL] [Abstract][Full Text] [Related]
17. Anal carcinoma or "just hemorrhoids"?
Winburn GB
Am Surg; 2001 Nov; 67(11):1048-58. PubMed ID: 11730221
[TBL] [Abstract][Full Text] [Related]
18. Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.
Hagemans JAW; Blinde SE; Nuyttens JJ; Morshuis WG; Mureau MAM; Rothbarth J; Verhoef C; Burger JWA
Ann Surg Oncol; 2018 Jul; 25(7):1970-1979. PubMed ID: 29691737
[TBL] [Abstract][Full Text] [Related]
19. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
[TBL] [Abstract][Full Text] [Related]
20. Anal adenocarcinoma: Treatment outcomes and trends in a rare disease entity.
Wegner RE; White RJ; Hasan S; Raj M; Monga D; Finley G; Kirichenko AV; McCormick J
Cancer Med; 2019 Jul; 8(8):3855-3863. PubMed ID: 31173487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
